StockComparison Logo
vs

PHXM vs LGVN

Comparison between PHAXIAM Therapeutics SA ADR (PHXM, Company) and Longeveron Inc - Class A (LGVN, Company).

Both PHXM and LGVN are from the Healthcare sector.

PHXM vs LGVN - Performance Comparison

Key Characteristics

Financial metrics and valuation ratios

Market Cap
Winner
PHXM
$20M
LGVN
$20M
Max Drawdown
Winner
PHXM
11.39%
LGVN
99.89%
Sharpe Ratio
Winner
PHXM
3.68
LGVN
0.20
5Y Beta
Winner
PHXM
0.00
LGVN
1.19
Industry
PHXM
Biotechnology
LGVN
Biotechnology
P/E Ratio
PHXM
-0.23
Winner
LGVN
-0.71
5Y EPS CAGR
PHXM
N/A
LGVN
-21.63%
Debt to Equity
PHXM
42.62%
Winner
LGVN
4.67%
Free Cash Flow Yield
PHXM
N/A
LGVN
-91.60%

PHXM vs LGVN - Historical Returns

Returns include dividend reinvestment.

1M
PHXM
N/A
LGVN
+21.30%
3M
PHXM
N/A
LGVN
-15.99%
6M
PHXM
N/A
LGVN
+48.78%
1Y
PHXM
N/A
LGVN
-32.22%
5Y(CAGR)
PHXM
N/A
LGVN
-59.14%
Max(CAGR)
Winner
PHXM
+58.44%
LGVN
-56.95%

PHXM vs LGVN - Annual Returns (2021 - 2026)

Returns include dividend reinvestment.

YearPHXMLGVN
2026+0.00%+38.30%
2025N/A-71.73%
2024N/A-86.89%
2023-5.06%-59.64%
2022N/A-73.37%
2021N/A+62.89%

PHXM vs LGVN Drawdown Comparison

The maximum drawdown for PHXM was -11.39%, occurring on Jul 5, 2023. Recovery took 5 trading sessions.

The maximum drawdown for LGVN was -99.89%, occurring on Mar 6, 2026. This drawdown has not yet recovered.

The current LGVN drawdown is -99.81%.

RankPHXMLGVN
#1-11.39%
Jun 29, 2023 - May 29, 2026
-99.89%
Nov 24, 2021 - Mar 6, 2026
#2N/A-65.44%
Mar 11, 2021 - Nov 19, 2021
#3N/A-38.94%
Nov 22, 2021 - Nov 24, 2021
#4N/A-17.98%
Feb 16, 2021 - Feb 24, 2021
#5N/A-16.61%
Mar 2, 2021 - Mar 11, 2021
#6N/A-3.79%
Feb 24, 2021 - Feb 26, 2021
#7N/A-1.25%
Feb 26, 2021 - Mar 2, 2021

Correlation

Correlation between PHXM and LGVN is -1.00 which considered as a very strong negative correlation - the stocks move almost identically in opposite directions.

-1.00
-101

Select Stocks to Compare